Molecular mimicry and cancer vaccine development
Abstract Background The development of cancer immunotherapeutic strategies relies on the identification and validation of optimal target tumor antigens, which should be tumor-specific as well as able to elicit a swift and potent anti-tumor immune response. The vast majority of such strategies are ba...
Main Authors: | Maria Tagliamonte, Beatrice Cavalluzzo, Angela Mauriello, Concetta Ragone, Franco M. Buonaguro, Maria Lina Tornesello, Luigi Buonaguro |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12943-023-01776-0 |
Similar Items
-
Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
by: Concetta Ragone, et al.
Published: (2022-07-01) -
Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case
by: Carmen Manolio, et al.
Published: (2022-10-01) -
Lack of shared neoantigens in prevalent mutations in cancer
by: Concetta Ragone, et al.
Published: (2024-04-01) -
The impact of antigenic molecular mimicry on anti-cancer T-cell immune response
by: Maria Tagliamonte, et al.
Published: (2022-10-01) -
Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides
by: Angela Mauriello, et al.
Published: (2021-12-01)